Charming Medical Limited Class A Ordinary Shares
NASDAQ:MCTAMedical - Care Facilities
+$0.00 today
- Market cap
- $445.55M
- Beta
- 0.00
- P/E (TTM)
- 414.6
- EPS (TTM)
- $0.07
Volume 0.00M
Average 0.87M
MCTA Deferred Revenue (Non-current)
Payments received for goods or services the company will deliver after more than one year.
Charming Medical Limited Class A Ordinary SharesNASDAQ: MCTA
Deferred Revenue (Non-current) · Q4 FY2024 · quarter ended Mar 2025
Deferred revenue (non-current) remains negative
Q4 FY2024 deferred revenue (non-current) was $0, compared with $0 a year earlier.
Context
- Deferred revenue (non-current) amounted to 0.0% of total assets at the end of Q4 FY2024, unchanged from a year earlier.
- Deferred revenue (non-current) increased in 0 of the last 2 fiscal years.
- FY2024 was the highest annual figure in the 3 fiscal years shown.
Sources:Balance SheetText generated from reported figures; not investment advice.
Deferred Revenue (Non-current) history
USD · from the balance sheet
- Latest · FY2024
- 0 USD
- Year-over-year change
- —
| Period | Period end | Deferred Revenue (Non-current) | YoY change |
|---|---|---|---|
| FY2024 | 2025-03-31 | 0 | — |
| FY2023 | 2024-03-31 | 0 | — |
| FY2022 | 2023-03-31 | 0 | — |
Deferred Revenue (Non-current) vs competitors
How MCTA compares with its peers on the latest reported figures
- MCTA's Mar 2025 deferred revenue (non-current) of $0 is the 2nd highest of the 10 companies compared; the peer median is $0.
- Deferred revenue (non-current) amounts to 0.0% of total assets for MCTA, versus a peer median of 0.0%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $1.62M | — | — | 0.3% | |
MCTACharming Medical Limited Class A Ordinary Shares | Mar 2025 | $0 | — | — | 0.0% |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Feb 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Peer median (excluding MCTA) | $0 | — | — | 0.0% | |
Competitors are the stored peer set for MCTA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Charming Medical Limited Class A Ordinary Shares
NASDAQ:MCTA
Intrinsic Alpha fair value
Locked
Current Price
$29.36
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.